Trial Profile
Efficacy of sofosbuvir plus ledipasvir versus sofosbuvir plus simeprevir in patients with acute hepatitis C
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 May 2016
Price :
$35
*
At a glance
- Drugs Ledipasvir (Primary) ; Simeprevir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms SLAM C
- 17 Apr 2016 Efficacy results (n=29) presented at The International Liver Congress 2016.
- 29 Feb 2016 New trial record